Advances in Prognostic Methylation Biomarkers for Prostate Cancer

There is a major clinical need for accurate biomarkers for prostate cancer prognosis, to better inform treatment strategies and disease monitoring. Current clinically recognised prognostic factors, including prostate-specific antigen (PSA) levels, lack sensitivity and specificity in distinguishing a...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Dilys Lam, Susan Clark, Clare Stirzaker, Ruth Pidsley
Format: Artigo
Langue:Inglês
Publié: MDPI AG 2020-10-01
Collection:Cancers
Sujets:
DNA methylation
epigenetics
biomarkers
circulating DNA
cfDNA
prostate cancer
Accès en ligne:https://www.mdpi.com/2072-6694/12/10/2993
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires